Advertisement

Advertisement

TSE:BCT Stock Latest News

BriaCell presents anti-cancer activity of Bria-OTS

The FlyBriaCell presents anti-cancer activity of Bria-OTS

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

PremiumThe Fly

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

8d ago

BriaCell Therapeutics Reports Rising Losses and Funding Pressure

PremiumCompany Announcements

BriaCell Therapeutics Reports Rising Losses and Funding Pressure

27d ago

BriaCell’s Completed Breast Cancer Combo Study Moves Immunotherapy Story Forward

PremiumCompany Announcements

BriaCell’s Completed Breast Cancer Combo Study Moves Immunotherapy Story Forward

1M ago

BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR

PremiumCompany Announcements

BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR

1M ago

BriaCell to present four posters at the 2026 AACR

PremiumThe FlyBriaCell to present four posters at the 2026 AACR

1M ago

BriaCell Shareholders Approve Auditors and Reelect Board

Company Announcements

BriaCell Shareholders Approve Auditors and Reelect Board

2M ago

BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting

Company Announcements

BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting

2M ago

BriaCell Restructures Soluble CD80 Program via BriaPro Deal

PremiumCompany Announcements

BriaCell Restructures Soluble CD80 Program via BriaPro Deal

2M ago

BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal

PremiumCompany Announcements

BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal

2M ago

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

PremiumThe Fly

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

2M ago

BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial

PremiumCompany Announcements

BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial

2M ago

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

PremiumThe FlyBriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

2M ago

BriaCell Imaging Data Show Tumor Regression and Immune Activation in Metastatic Breast Cancer Trial

Company Announcements

BriaCell Imaging Data Show Tumor Regression and Immune Activation in Metastatic Breast Cancer Trial

3M ago

BriaCell says patient images show regression, resolution of metastsized tumors

The Fly

BriaCell says patient images show regression, resolution of metastsized tumors

3M ago

BriaCell Reports Prolonged Survival in Phase 2 Metastatic Breast Cancer Trial

PremiumCompany Announcements

BriaCell Reports Prolonged Survival in Phase 2 Metastatic Breast Cancer Trial

3M ago

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

PremiumThe Fly

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

3M ago

BriaCell Therapeutics Completes $30 Million Public Offering

PremiumCompany Announcements

BriaCell Therapeutics Completes $30 Million Public Offering

3M ago

BriaCell Raises $30 Million Through Public Offering of Units and Listed Warrants

PremiumCompany Announcements

BriaCell Raises $30 Million Through Public Offering of Units and Listed Warrants

3M ago

BriaCell Therapeutics trading resumes

PremiumThe FlyBriaCell Therapeutics trading resumes

3M ago

BriaCell Therapeutics trading halted, volatility trading pause

The Fly

BriaCell Therapeutics trading halted, volatility trading pause

3M ago

BriaCell Reports Year-Long Complete Lung Metastasis Response in Breast Cancer Trial

Company Announcements

BriaCell Reports Year-Long Complete Lung Metastasis Response in Breast Cancer Trial

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >